Agirbasli, H.Otlu, B.Bilgen, H.Durmaz, R.Gedikoglu, G.2024-08-042024-08-0420080300-81261439-0973https://doi.org/10.1007/s15010-007-6246-1https://hdl.handle.net/11616/94524[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessFluconazole ProphylaxisMarrow TransplantationRisk-FactorsInfectionMortalityIncreaseTherapyTrendsEpidemiological characteristics of fatal Candida krusei fungemia in immunocompromised febrile neutropenic childrenLetter36188911808471910.1007/s15010-007-6246-12-s2.0-43049168343Q1WOS:000253200600020Q4